Addressing Access
- The Abbott Fund is helping improve the lives of children affected by HIV by advancing pediatric treatment, and through community-based programs to support orphans and vulnerable children.
Our Business Strategy
A core part of our business strategy is to ensure that those who can benefit from our medicines and medical products have access to them. It begins with broad registration of our products in countries where specific diseases are prevalent. We collaborate with regulators, patient groups, medical organizations and other stakeholders to ensure that our medicines and medical products are fairly priced or, in the case of public health care systems, adequately reimbursed, so patients who need them can afford them. We also ensure sufficient global product supply. For example, we completed construction of the Abbott Biotechnology plant in Puerto Rico to help support our growth in biologic drugs, including Humira. We built new manufacturing facilities in Ireland to produce vascular care products and are constructing a nutritional powder manufacturing plant in Singapore – our largest nutritional investment ever – to meet the rapidly growing demand for our products in Asia. We actively seek partnerships to help get our products to those patients in greatest need.
Reaching Across Health Care Divides
While our business strategy goes a long way toward improving access, patients still face many obstacles. Products will be unaffordable for those without insurance. In other cases, lack of awareness means lack of access. Our approach is to work with governments, nonprofit organizations and patient groups to develop sound public policy, build health systems and design philanthropic programs to assist patients.
